An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
Alessio Accardi, professor of physiology and biophysics in anesthesiology at Weill Cornell Medicine, has been awarded a five-year, $2.7 million grant for fundamental research on cell membrane proteins that have critical roles in biology and are involved in numerous human diseases.
The 2024 CROPPS Annual Meeting and Symposium held in October in the Sonoran Desert region of Arizona provided an ideal stage for discussions on sustainable agriculture in hot, dry environments.
Cornell Tech has launched a new digital guide highlighting the many cultural attributes of its campus on Bloomberg Connects, the free arts and cultural app created by Bloomberg Philanthropies.
Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy app significantly reduced anxiety in young adults struggling with mental health challenges.
The fireside chat was part of a two-day visit by Dr. Robert M. Califf, commissioner of the U.S. Food and Drug Administration, who focused on medicine and health care innovations.
Using experiments with COVID-19 related queries, Cornell sociology and information science researchers found that in a public health emergency, most people pick out and click on accurate information.
Vaccinating mothers against RSV during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Cornell researchers have developed a bioelectric device that can detect and classify new variants of coronavirus, and potentially other viruses, such as measles and influenza, to identify those that are most harmful.